KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Cash & Equivalents (2016 - 2026)

Cardlytics filings provide 11 years of Cash & Equivalents readings, the most recent being $35.7 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 31.46% to $35.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $35.7 million through Mar 2026, down 31.46% year-over-year, with the annual reading at $48.7 million for FY2025, 25.73% down from the prior year.
  • Cash & Equivalents hit $35.7 million in Q1 2026 for Cardlytics, down from $48.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $208.3 million in Q1 2022 and bottomed at $35.7 million in Q1 2026.
  • Average Cash & Equivalents over 5 years is $92.2 million, with a median of $90.1 million recorded in 2023.
  • The largest annual shift saw Cash & Equivalents tumbled 66.05% in 2022 before it fell 22.61% in 2024.
  • Cardlytics' Cash & Equivalents stood at $121.9 million in 2022, then dropped by 24.67% to $91.8 million in 2023, then decreased by 28.57% to $65.6 million in 2024, then dropped by 25.73% to $48.7 million in 2025, then decreased by 26.78% to $35.7 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Cash & Equivalents are $35.7 million (Q1 2026), $48.7 million (Q4 2025), and $44.0 million (Q3 2025).